Valley Brook Capital Group’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,300	Closed	-$21K	–	240
2021 Q1	$21K	Hold	1,300	–	–	0.02%	304
2020 Q4	$27K	Buy	+1,300	New	+$27K	0.03%	254